Methodological considerations for the use of heart rate variability as a measure of pain reactivity in vulnerable

Tim Oberlander1, J Philip Saul

  • 1Division of Developmental Pediatrics, University of British Columbia, Centre for Community Child Health Research, Children's and Women's Health Centre of B.C., 4480 Oak Street, Vancouver, B.C. V6N 2H4, Canada. toberlander@cw.bc.ca

Clinics in Perinatology
|October 17, 2002
PubMed

Insights

Heart rate (HR) and heart rate variability (HRV) can indicate pain in preterm infants, but NICU factors can complicate interpretation. Flexible analysis is key to understanding these cardiovascular responses to pain.

Area of Science:

  • Neonatal physiology
  • Pain assessment
  • Cardiovascular monitoring

Background:

  • Heart rate (HR) and heart rate variability (HRV) provide indices of pain reactivity, especially in preterm and ill infants with ambiguous distress signals.
  • Pain perception mechanisms are present even in preterm infants, leading to generally consistent HR and HRV responses across settings.
  • Preterm birth and NICU environments introduce factors that can influence and alter the specificity of HR and HRV as pain measures.

Purpose of the Study:

  • To explore the utility and challenges of using HR and HRV to assess pain reactivity in vulnerable infants within the NICU setting.
  • To highlight the impact of developmental and contextual factors on cardiovascular responses to pain in neonates.

Main Methods:

  • Review of existing literature and methodologies for measuring and analyzing HR and HRV in infants.
  • Discussion of factors influencing cardiovascular responses, including infant health, developmental stage, behavioral state, medication, and setting.
  • Emphasis on the need for flexible analytical approaches, including various HRV techniques and careful selection of HR data epochs.

Main Results:

  • HR and HRV responses can be influenced by NICU contextual factors, potentially masking or altering the apparent pain reactivity.
  • Cardiovascular reactivity may reflect biologic capacity rather than actual pain response in some cases.
  • Discordance between biologic and behavioral measures, medication effects, and developmental changes are critical considerations.

Conclusions:

  • Assessing pain reactivity using cardiovascular measures in vulnerable infants requires careful consideration of multiple influencing factors.
  • Flexible and comprehensive analytical strategies are necessary to accurately interpret HR and HRV responses to painful events.
  • Further research is needed to refine the understanding of cardiovascular reactivity as a measure of pain in NICU populations.